Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes
Clinical trial NCT02583919 · COMPLETED
Trial details
- NCT number
- NCT02583919
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-12-15
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.